Targeted Intra-arterial Gemcitabine vs. Continuation of IV Gemcitabine Plus Nab-paclitaxel Following Induction with Sequential IV Gemcitabine Plus Nab-paclitaxel and Radiotherapy for Unresectable Locally Advanced Pancreatic Cancer (TIGeR-PaC): A Randomize

Press/Media

Period21 Jan 2023

Media coverage

1

Media coverage

  • TitleTargeted Intra-arterial Gemcitabine vs. Continuation of IV Gemcitabine Plus Nab-paclitaxel Following Induction with Sequential IV Gemcitabine Plus Nab-paclitaxel and Radiotherapy for Unresectable Locally Advanced Pancreatic Cancer (TIGeR-PaC): A Randomize
    Media name/outletMarketScreener.com
    Country/TerritoryUnited States
    Date21/01/23
    URLct.moreover.com/?a=49801995268&p=1gw&v=1&x=c809dNiiTVZdYP0h_ywd_g
    PersonsKaryn Goodman
View all 1
View less